Chronos Archive seal

Review checklist: Swami Vivekananda (HR-NI032)

All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments

Everything a reviewer needs to judge, gathered from the record. Release status: draft.

Review status

ReviewStatusReviewerDateNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the classification as type 2 diabetes (GAD antibodies negative, C-peptide preserved, no ketosis), metformin alone at diagnosis with an A1c of 9.4 percent by his choice, the delay of the SGLT2 inhibitor until albuminuria was confirmed, losartan for stage 1 hypertension with albuminuria, the statin at 35, the adapted IDF-DAR fasting plan, the missed three-month A1c and post-statin lipid checks while he travelled, the prednisone course in a man with diabetes, and asthma on GINA track 1.
provenance reviewnot_startedHe died in 1902; the recent-death rule does not apply. Claims rest on the Belur Math biography, three chapters of Swami Nikhilananda's biography, and seven of his own letters in the Complete Works (via Wikisource). His diabetes (1897), insomnia (1897), asthma (1898 to 1901) and albuminuria are documented in his own words; the classification of his diabetes, his kidney disease and the cause of his death are R.
safe messaging reviewnot_startedNo mental health or substance claim is made; mood screens are synthetic and negative. His monastic life, diet and fasts are described with respect and left to his choice. His death is recorded once, with the physicians' and the monks' understandings side by side. No disciple, brother monk or other real person is named or given a role in the modern episode.

Judgment calls (dossier editorial resolutions)

  1. Recent-death rule. He died in 1902, so the rule does not apply. The claims are still limited to what the fetched sources state.
  2. Name. “Swami” is a monastic title, not a given name, and Vivekananda is a monastic name with no family name. The display name is “Swami Vivekananda,” as he is known; `identity.name_parts` is `{given: [], family: "Vivekananda"}`, as for other single names, so exchange documents carry “Vivekananda” as the name and the title is not treated as a given name. His birth name, Narendranath Datta (also written Narendra Nath Datta), is recorded as an alias; neither form appears in any other record.
  3. Another figure. The brief noted that a Bengali contemporary has a record in the dataset (HR-ET021); no claim needs him and he is not named, so `historical_mentions` is not used. His disciples, brother monks and Western friends appear only as recipients of the letters cited; none is given a role in the modern episode.
  4. Sources not read. The Advaita Ashrama edition of the Complete Works was read through Wikisource transcriptions; The Life of Swami Vivekananda by His Eastern and Western Disciples and Sankar’s The Monk as Man (said in secondary sources to list 31 ailments) were not read and are not cited. No peer-reviewed article on his illnesses was found and read; none is cited. The Vedanta Society pages were not reached.
  5. Diabetes (D). His diabetes is documented in his own letters from March and April 1897, at 34, with his physicians’ advice to go to Darjeeling (CLM-0005). How it was diagnosed is not recorded. He called it “a hereditary foe”; no relative is named, so the family history records only “family member” with his words, graded D. His classification as type 2 is retrospective (CLM-0014, R, possible).
  6. Corrections to the brief. The brief asked for an index age of 35 to 37 with diabetes first diagnosed in the modern episode. His diabetes was documented at 34, so the modern episode presents him at 35 as a man told of diabetes a year earlier and never tested, whose thirst and weight loss resolve into a confirmed and classified diagnosis at the second visit. The brief described a “vegetarian” diet; his letters show he also ate meat and fish (in 1897 he wrote of “eating only meat,” and in 1901 his doctors forbade meat), so the modern diet is mostly vegetarian with fish at some meals, by his choice. The brief said he traveled to the West in 1899 to 1900; the Belur Math biography confirms June 1899 to December 1900, and the modern visits avoid it.
  7. Kidney disease. His own letters report albuminuria “the last three years” before December 1901 (that is, from about 1898) and a diagnosis of Bright’s disease (CLM-0011, D). His biographer describes dropsy in his last illness (CLM-0012, D, probable). That this was diabetic kidney disease is retrospective (CLM-0015, R, possible). The modern albuminuria and the diabetic kidney disease (E11.21) are synthetic and linked to these claims.
  8. Death. He died at the Belur Math on July 4, 1902, at 39 (D). The physicians’ cause, as his biographer records it, was “apoplexy or sudden failure of the heart”; the frequently repeated “rupture of a blood vessel in the brain” was not found in a fetched primary or authoritative source and is recorded only as a retrospective interpretation (CLM-0016, R, disputed). The monks’ understanding of his death as samadhi is recorded alongside it, with respect.
  9. Index age and dates. The synthetic date of birth is January 12, 1991 (shift 128 years). The index visit on February 9, 2026 maps to February 9, 1898, when he was 35, at Calcutta and Belur, where the monastery moved that month. The visits map to February 9 and 16, March 9 and March 23, 1898 (before he left for Darjeeling on March 30), and October 20 and 27, 1898 (after his return to Belur on October 18). The long gap matches his documented travels in the north from May to October 1898. The visits are not a claim about his real care.
  10. Presenting problems. Hyperglycemia with thirst and weight loss (R73.9) is resolved at the diagnosis visit on February 16, 2026, when type 2 diabetes (E11.65, both_with_link), moderately increased albuminuria on a first sample (R80.9) and mixed hyperlipidemia (E78.2) are recorded. The raised blood pressure reading (R03.0) is resolved at the preventive visit on March 9, when hypertension (I10) is recorded. The albuminuria is resolved on October 27, when diabetic kidney disease (E11.21) is recorded after three abnormal samples over eight months. The wheeze and breathlessness of the sick visit (R06.2) are resolved on October 27, when asthma (J45.40) is confirmed by spirometry. Insomnia (G47.00, both_with_link) is recorded at intake from his own words.
  11. Classification of diabetes. GAD65 antibodies negative, fasting C-peptide preserved and no ketosis: type 2, not type 1 or slowly progressive autoimmune diabetes. The consultant advises rechecking antibodies if he loses weight again or needs rapidly escalating treatment.
  12. Treatment choices. Metformin extended-release alone at an A1c of 9.4 percent, by his choice after early combination therapy and a GLP-1 receptor agonist were discussed; sulfonylureas avoided because of fasting; losartan for stage 1 hypertension with albuminuria (an ARB to avoid an ACE inhibitor's cough); atorvastatin 10 mg at 35 with diabetes, South Asian ancestry, albuminuria and hypertension, by his choice; the SGLT2 inhibitor deferred until albuminuria was confirmed and he was home from months of travel, then started with fasting and sick-day rules; prednisone for a moderate asthma attack with glucose monitoring, without insulin; GINA track 1 step 3 for uncontrolled adult-onset asthma. These are clinical judgment calls for review.
  13. Fasting. The IDF-DAR guidance was written for Ramadan; it is adapted to Hindu fasts (fortnightly fasts with fruit and milk, and festival fasts that may be without water) for risk stratification, medication timing, glucose checks and thresholds for breaking a fast. His fasts, diet and monastic practice are his decisions; the clinic adapts the plan to them. The fasts in the modern episode are synthetic; his own fasting practice was not researched.
  14. Thin chart (rule 26). His documented health history is richer than most in this batch but rests mainly on his own letters and one biography by a monk of his order. Only diabetes, insomnia, asthma, albuminuria and the reported Bright’s disease and dropsy are used; the many other ailments attributed to him in secondary sources are not.
  15. Tobacco. His tobacco use in life was not researched. The modern episode records “no tobacco use now” and makes no claim about his past.
  16. Preventive visit. A periodic preventive visit at 35 (CPT 99395, 99497 and vaccine codes in plain text): PHQ-9 3, GAD-7 2, AUDIT-C 0; hepatitis B and latent tuberculosis screening because he was born in India, with HIV and hepatitis C; Tdap and hepatitis B vaccination (diabetes); PCV20, influenza and COVID-19 at diagnosis; voluntary advance care planning with an unnamed brother monk as his agent and his wish to die at the monastery with the rites of his tradition.
  17. Sick visit. A moderate attack of asthma two days after his return to the damp plains (R06.2, resolved when asthma was confirmed), anchored to his documented “suffocating attacks of asthma” on his return to Belur in October 1898. Heart failure and pneumonia were excluded by examination, chest X-ray and ECG; prednisone was given with glucose monitoring.
  18. Focused visits. The three chronic-care follow-ups (diagnosis and consultation; five weeks, before his journey; and after seven months away, a week after the asthma attack) are documented on the ADA Standards of Care 2026, the CMID monographs, KDIGO 2024, IDF-DAR 2021 adapted, and GINA 2025. Two protocol deviations are recorded instead of invented results: the A1c due three months after the metformin increase, and the lipid panel due four to twelve weeks after starting atorvastatin, were both missed while he travelled; no harm (A1c 6.9 percent and LDL 84 mg/dL when checked); corrective action: point-of-care or mail-in testing and a video visit before any journey longer than two months. The second hepatitis B dose was delayed to his return without restarting the series. The review within a week of the asthma attack was kept.
  19. Consultation. The endocrinology referral and consultation by Rohan Lindqvist-Bose, MD (fictional), on the diagnosis day, are S. The consultant answers six questions consistently with what followed: type 2 diabetes; no insulin; metformin with the evening meal and an SGLT2 inhibitor once albuminuria is confirmed; an adapted IDF-DAR fasting plan; an ARB if blood pressure stays raised; and targets, eye and foot checks, B12 and a statin.
  20. Synthetic clinical picture. All visits, results, spirometry, FeNO, retinal photographs, his height (172 cm) and weights, his diet and fasting pattern, and every medicine and vaccine are synthetic. Qualitative results (urine dipstick, interferon-gamma release assay, hepatitis B, HIV and hepatitis C screening, rapid viral tests) are in note text.
  21. Real people. No disciple, brother monk, relative or other real person is named in the modern episode or given a decision, statement or health fact; his health care agent is unnamed.

Protocol deviations

Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.

VisitMeasureIntervalWhat happened
2026-10-27
Progress note 06 (C-CDA)
A1c three months after the change in therapyQuarterly after a change in therapyMissed: due three months after the metformin dose increase, while he was travelling in the mountains, and he could not find a laboratory. No harm resulted judging by today's A1c of 6.9 percent and his monthly fasting readings of 110 to 135 mg/dL. Corrective action: a point-of-care or mail-in A1c kit and a video visit are now arranged before any journey longer than two months
2026-10-27
Progress note 06 (C-CDA)
Lipid panel after starting a statinFour to twelve weeks after startingMissed: due six to twelve weeks after starting atorvastatin, during his travels; done today, seven months after starting: LDL 84, triglycerides 146. No harm resulted. Corrective action: as for the A1c, testing before long journeys is now planned

Orders and referrals without results in the record

VisitTypeItemStatusDetail
2026-02-16
Progress note 02 (C-CDA)
ReferralDilated eye examination or retinal photographsOrderedRetinal photographs booked for the next visit
2026-02-16
Progress note 02 (C-CDA)
Self-managementDiabetes self-management education and medical nutrition therapyReferredDietitian this week: a mostly vegetarian plan built on his monastery meals
2026-03-09
Progress note 03 (C-CDA)
PreventionHepatitis B screeningOrderedBorn in a country where hepatitis B is common; drawn today
2026-03-09
Progress note 03 (C-CDA)
PreventionLatent tuberculosis infection screeningOrderedBorn in a country where tuberculosis is common; interferon-gamma release assay drawn today
2026-03-09
Progress note 03 (C-CDA)
PreventionHIV and hepatitis C screeningOrderedOnce-in-adulthood tests drawn today with his agreement
2026-03-09
Progress note 03 (C-CDA)
PreventionDiabetic eye examinationOrderedRetinal photographs booked for the next visit
2026-03-23
Progress note 04 (C-CDA)
Self-managementInsomnia treatmentReferredCognitive behavioral therapy for insomnia by video

Evidence to check

Retrospective claims (R)

ClaimStatementCertainty
CLM-0014Retrospective interpretation: diabetes beginning at about 34 in a man of South Asian ancestry who called it hereditary, who lived five more years without insulin, and whose thirst and sugar came and went with diet and rest, is most consistent with type 2 diabetes; slowly progressive autoimmune diabetes cannot be excluded from the record.possible
CLM-0015Retrospective interpretation: albuminuria from about 1898, a diagnosis of Bright's disease, a bleed in the eye and swelling of the feet late in his life are consistent with diabetic kidney disease, perhaps with high blood pressure, but no measurement survives and other kidney or heart disease cannot be excluded.possible
CLM-0016Retrospective interpretation: his sudden death, which many accounts describe as the rupture of a blood vessel in the brain, could have been a brain hemorrhage or a heart event; the physicians' "apoplexy or sudden failure of the heart" does not decide between them, and his followers understand it as samadhi.disputed

Sensitive claims

None.

Diagnoses not confirmed

None.

Notes to read

Every note in the record, with its type. All clinical content is synthetic.

Abnormal results

DateResultValueFlag
2026-02-09Glucose (random)246 mg/dL (high)High
2026-10-20Peak expiratory flow330 L/min (low)Low
2026-02-16Hemoglobin A1c9.4% (high)High
2026-02-16Glucose (fasting)172 mg/dL (high)High
2026-02-16Urine albumin-to-creatinine ratio46 mg/g (high)High
2026-02-16Total cholesterol214 mg/dL (high)High
2026-02-16HDL cholesterol36 mg/dL (low)Low
2026-02-16Triglycerides228 mg/dL (high)High
2026-02-16LDL cholesterol132 mg/dL (high)High
2026-03-23Urine albumin-to-creatinine ratio41 mg/g (high)High
2026-10-27Hemoglobin A1c6.9% (high)High
2026-10-27Glucose (fasting)124 mg/dL (high)High
2026-10-27Urine albumin-to-creatinine ratio34 mg/g (high)High
2026-10-27HDL cholesterol39 mg/dL (low)Low
2026-10-27FEV1 before bronchodilator2.95 L (low)Low
2026-10-27FEV1 percent predicted before bronchodilator77% (low)Low
2026-10-27FEV1/FVC before bronchodilator0.66 (low)Low
2026-10-27FeNO44 [ppb] (high)High